Patients who suffer from mild to extreme mental health stress are less likely to participate in self-care behavior for diabetes.
Read More »Managing Editor, Diabetes in Control
Heart Failure as a Risk Factor for Diabetes and Prediabetes Patients
Diabetes or prediabetes may put a patient at higher risk of developing cardiovascular diseases.
Read More »How Can Exercise Be Used for Glucose Management and Prevention of Type 2 Diabetes Mellitus?
Like medication, exercise can be dosed based on the characteristics of the individual to increase its benefits and reduce side effects, substantially affecting glycemic control.
Read More »Tooth Loss Associated with Morbidity and Mortality
The impact of impaired healing in those with diabetes mellitus (DM) contributes to their higher risk of developing periodontitis, leading to tooth loss (TL).
Read More »Identifying Gestational Diabetes and its Causes
Gestational diabetes mellitus (GDM) is becoming more common, which calls for a deeper understanding of this disorder.
Read More »Low Testosterone Levels in Male Patients Linked to Increased Risk of CVD
All male patients with low testosterone levels are at a higher risk for cardiovascular disease, especially those with type 2 diabetes mellitus.
Read More »Novel Monoclonal Antibody Linked to Increased Muscle Development and Reduction in Body Fat
A new study reveals that bimagrumab can have metabolic improvement for those suffering from obesity and type 2 diabetes.
Read More »Mitochondrial Mutations and Diabetes
Mitochondrial function is crucial for maintaining cellular metabolism and growth and plays a role in some forms of diabetes. Diabetes mellitus causes much morbidity and mortality for Americans and people worldwide. In addition, it significantly reduces the quality of life and life span of patients that have diabetes. Mitochondrial dysfunction …
Read More »Influence of Intermittent Fasting on Health Outcomes
Data analysis reveals that intermittent fasting has positive health outcomes ranging from weight loss to elimination of metabolic stress.
Read More »Dapagliflozin Gets Nod as a Breakthrough Therapy Designation for CKD
Dapagliflozin (Farxiga®) has been granted U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation (BTD) for patients with chronic kidney disease (CKD), whether or not they have type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.